[Results of polychemotherapy in neoplasms of the lymphoreticular system].
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007239:Infections / Q000401:mortality; D007970:Leukopenia / Q000139:chemically induced; D008134:Long-Term Care; D008206:Lymphatic Diseases / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011344:Procarbazine; D014747:Vinblastine; D003520:Cyclophosphamide; D011239:Prednisolone
Ergebnisse der Polychemotherapie bei Neoplasien des lymphoretikulären Systems.